Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation
Citations Over TimeTop 10% of 2016 papers
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent for esophageal squamous cell carcinoma (ESCC). Forced expression of CHOP, one of the key downstream transcription factors during endoplasmic reticulum (ER) stress, upregulates the death receptor 5 (DR5) levels and promotes oxidative stress and cell death. In this study, we show that ER stress mediated by thapsigargin promoted CHOP and DR5 synthesis thus sensitizing TRAIL treatment, which induced ESCC cells apoptosis. These effects were reversed by DR5 siRNA in vitro and CHOP siRNA both in vitro and in vivo. Besides, chemically inhibition of AMPK by Compound C and AMPK siRNA weakened the anti-cancer effect of thapsigargin and TRAIL co-treatment. Therefore, our findings suggest ER stress effectively sensitizes human ESCC to TRAIL-mediated apoptosis via the TRAIL-DR5-AMPK signaling pathway, and that activation of ER stress may be beneficial for improving the efficacy of TRAIL-based anti-cancer therapy.
Related Papers
- → Modeling Acute ER Stress in Vivo and in Vitro(2016)120 cited
- → Klotho Ameliorates Chemically Induced Endoplasmic Reticulum (ER) Stress Signaling(2013)49 cited
- → The regulatory mechanism of 4-phenylbutyric acid against ER stress-induced autophagy in human gingival fibroblasts(2012)46 cited
- ER Stress에 의해 유발된 C6 Glial Cells의 손상에 대한 龍腦의 보호효과(2009)
- Inhibition of CaMKII Suppresses the Endoplasmic Reticulum Stress-induced Cardiomyocytes Death in Rats(2009)